Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Deals & business · first seen 16h ago, updated 16h ago

Eli Lilly and InnoCare Pharma agree on $3.3bn drug research deal

1 outlet Eli Lilly

The deal focuses on addressing critical unmet medical needs

Summary from PMLiVE.

Coverage 1 article · 1 outlet

  1. PMLiVE
    Eli Lilly and InnoCare Pharma agree on $3.3bn drug research deal